Max Bayer

@maxbayer.bsky.social

Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or maxbayer.10 on Signal. he/him

A 26-year-old collaboration between the government and top research centers to advance new pediatric brain cancer treatments is being wound down, an HHS spokesperson confirmed to @endpts.com. Money is being redirected to another childhood cancer funding channel. endpoints.news/hhs-winds-do...

HHS winds down pediatric brain tumor pact after 26 years, prioritizing other childhood cancer work

The National Cancer Institute said it will stop funding a 26-year-old collaboration with academic centers to help accelerate new pediatric brain tumor treatments.

endpoints.news

Vinay Prasad overrode Covid vaccine reviewers for a third time when he approved Moderna's Covid vaccine for at-risk young kids. The company had applied for approval for all kids 6 months to 11 years old, though its unclear what exactly reviewers decided. endpoints.news/prasad-overr...

Prasad again overrode FDA vaccine reviewers, this time on Moderna’s Covid shot for young kids

CBER chief Prasad overrides reviewers, approves Moderna's Covid shot only for at-risk kids 6mo-11yrs, marking his third override of review team recommendations.

endpoints.news

Without even addressing the merits of that goal, why does disconnecting from left-wing groups mean tying yourself to right-wing messaging? Regardless of whether it's meant to be ironic, the people behind this are implicitly conceding that Project 2025 as a package was good communication strategy.

Dave Weigel@daveweigel.bsky.social · last yr.

Put another way: Project 2025 let right-wing legal groups sketch out the agenda for a new GOP DOJ. Do you think "Project 2029" will hand the DOJ section to the ACLU? No. The opposite. It's about getting a Dem message disconnected from left-wing groups.

The FDA uploaded a number of new documents earlier this month involving Novavax's Covid-19 approval. New CBER chief Vinay Prasad wrote in a decisional memo that the harms of Covid vaccination may outweigh the benefits in "low-risk populations." endpoints.news/cber-chief-p...

CBER chief Prasad suggests Covid vaccine harms may outweigh benefits in 'low-risk populations'

CBER director Vinay Prasad says the benefits of Covid-19 vaccination have depreciated and may no longer outweigh the risks in adults who aren’t prone to more severe illness.

endpoints.news

We are a crossroads. CDC immunization schedule lists a shared clinical decision-making recommendation for healthy kids. But HHS reiterates in a statement to me that recommendations have been removed for that group and pregnant women.

Moderna's response to HHS saying that mRNA technology "remains under-tested" after axing funding for a bird flu vaccine: "Results during the pandemic speak for themselves, including demonstrated efficacy and a safety profile established in over a billion people worldwide."

At the risk of sounding too horse race-y, Lykos' pain last year was Compass' gain in the race for the first FDA approved #psychedelic. My colleague Ayisha Sharma has a deeply reported story on the new frontrunner, and how commercial preparations are already underway. endpts.com/a-new-dawn-f...

A new dawn for psychedelics? Compass could be the first to find out

Compass awaits Phase 3 COMP360 trial results for treatment-resistant depression amid renewed optimism for psychedelics.

endpts.com